Steen v. Bayer, et al.

Bayer Corporation

Our firm successfully represented Bayer in obtaining summary judgment in a case involving Bayer's flagship product, low dose aspiring. Despite the evidence confirming overdose, plaintiff sought to blame Bayer for the resulting injuries. The court found plaintiff could not prove her injuries came from having an adverse reaction to a below recommended amount of aspirin, rather than an overdose. The Ninth Circuit affirmed. 

Email Disclaimer